7-92163571-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001161528.2(LRRD1):āc.1632A>Cā(p.Gln544His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,531,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001161528.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRD1 | NM_001161528.2 | c.1632A>C | p.Gln544His | missense_variant | 2/6 | ENST00000458448.6 | NP_001155000.1 | |
CYP51A1-AS1 | NR_122109.1 | n.1039-1409T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRD1 | ENST00000458448.6 | c.1632A>C | p.Gln544His | missense_variant | 2/6 | 5 | NM_001161528.2 | ENSP00000405987 | P1 | |
LRRD1 | ENST00000343318.9 | c.-30-4368A>C | intron_variant | 1 | ENSP00000339642 | |||||
CYP51A1-AS1 | ENST00000453068.1 | n.998-1409T>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000217 AC: 3AN: 138374Hom.: 0 AF XY: 0.0000407 AC XY: 3AN XY: 73776
GnomAD4 exome AF: 0.0000638 AC: 88AN: 1379480Hom.: 0 Cov.: 31 AF XY: 0.0000662 AC XY: 45AN XY: 680270
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.1632A>C (p.Q544H) alteration is located in exon 1 (coding exon 1) of the LRRD1 gene. This alteration results from a A to C substitution at nucleotide position 1632, causing the glutamine (Q) at amino acid position 544 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at